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Abstract Despite the rapid and enormous progress in
biotechnologies, the biochemical analysis of membrane
proteins is still a difficult task. The presence of the large
hydrophobic region buried in the lipid bilayer membrane
(transmembrane domain) makes it difficult to analyze
membrane proteins in standard assays developed for
water-soluble proteins. To handle membrane proteins, the
lipid bilayer membrane may be used as a platform to
sustain their functionalities. Relatively slow progress in
developing micro total analysis systems (μTAS) for
membrane protein analysis directly reflects the difficulty
of handling lipid membranes, which is a common problem
in bulk measurement technologies. Nonetheless, researchers
are continuing to develop efficient and sensitive analytical
microsystems for the study of membrane proteins. Here, we
review the latest developments, which enable detection of
events caused by membrane proteins, such as ion channel
current,membrane transport,and receptor/ligand interaction,
by utilizing microfabricated structures. High-throughput
and highly sensitive detection systems for membrane
proteins are now becoming a realistic goal. Although most
of these systems are still in the early stages of development,
we believe this field will become one of the most important
applications of μTAS for pharmaceutical and clinical screen-
ings as well as for basic biochemical research.
Keywords Microtechnology.Membraneprotein.Lipid
bilayer.Ionchannel.Transporter
Introduction
Significant progress has been made in the field of micro total
analysissystems (μTAS) and lab-on-a-chipinthe last several
decades [1, 2]. Microfabrication and microfluidic technol-
ogies enabled the development of miniaturized analytic and
diagnostic tools in biology, including DNA/protein array
chips [3, 4], microchannel electrophoresis [5–7], and micro
immunoassay systems [5, 8]. Reactions of biomolecules
contained in small volumes of buffer are efficiently
controlled in sophisticated microfluidic systems, on the
premise that the molecules are water-soluble.
Membrane proteins are a class of proteins present in the
plasma membrane of cells. They perform specific roles in the
cell boundary, enabling cells to sense, communicate, and
regulate in response to fluctuations in the outside world. The
hydrophobic regions in the polypeptide chain of membrane
proteins penetrate into the inner hydrophobic layer of the
lipid bilayer. Thus, the presence of the large hydrophobic
part makes the membrane proteins notoriously difficult to
separatefrom themembrane andhandle inwater-basedassay
systems. To create a microanalysis system for studying
membrane proteins, it is necessary to construct an efficient
and easily useable platform to handle the plasma membrane
or the lipid bilayer.
In this review, we discuss the recent developments in
μTAS and biochip technologies that are contributing to the
Anal Bioanal Chem (2008) 391:2695–2702
DOI 10.1007/s00216-008-1916-0
H. Suzuki: S. Takeuchi (*)
Institute of Industrial Science, The University of Tokyo,
Komaba 4-6-1, Meguro-ku,
Tokyo 153-8505, Japan
e-mail: takeuchi@iis.u-tokyo.ac.jp
Present address:
H. Suzuki
Graduate School of Information Science and Technology,
Osaka University,
Yamadaoka 2-1, Suita,
Osaka 565-0871, Japan
e-mail: suzuki@ist.osaka-u.ac.jpfunctional analysis of membrane proteins. We first introduce
the technologies for the measurement of membrane protein
functions expressed on intact cell membranes, and then
introduce the technologies which utilize reconstituted (arti-
ficial) membranes. We have classified the use of reconsti-
tuted membranes into three major subcategories based on
their forms: (1) suspended lipid bilayers, planar membranes
suspended over a small aperture, (2) supported lipid bilayers,
planar membranes spanning a solid substrate, and (3)
liposomes, spherical lipid vesicles. Here we especially focus
on developments in the area of suspended bilayer systems,
whereas applications of the other two categories are diverse
and are discussed in other excellent reviews (e.g., [9–11]).
The membrane proteins to be discussed are categorized by
function into three groups: regulation of ion flow across the
membrane by ion channel proteins, regulation of other
molecules by transporter proteins, and association/dissoci-
ation of ligand molecules onto the receptor proteins. Like
other applications, μTAS architectures for the study of
membrane protein are oriented toward either or both of two
directions: highly sensitive detection, ideally down to the
single-protein level, and array systems for high-throughput
screening applications.
Cell-membrane-based systems
In nature, membrane proteins function in intact cell
membranes. The most straightforward way is to directly
examine the membrane proteins on isolated or cultured cells.
In this section, we review the use of microstructures for the
analysis of membrane proteins expressed on the plasma
membrane.
Ion channel recording
The patch-clamping technique, which was introduced by
Neher and Sakmann [12] in 1976, is the most prominent
technique in the history of membrane protein (ion channel)
research. In this method, a sharp glass capillary (patch-
clamp electrode) is pressed against the plasma membrane of
the cell, and suction is applied to form a tight seal (gigaohm
seal) between the membrane and the electrode. In the case
of whole-cell recording, further suction is applied to rupture
the membrane inside the capillary tip, providing electrical
access to the inner space of the cell. The electric current and
voltage across the membrane can be precisely controlled
and measured using a patch-clamp amplifier (Fig. 1a). By
using other variations of this technique, one can record the
ion flow through a single ion channel protein.
Since ion channels are extremely important as a drug
target, a high-throughput screening system on drug com-
pounds is strongly desired especially in the pharmaceutical
industry [13–15]. However, using the conventional patch-
clamping technique involves laborious and time-consuming
processes. One has to manipulate the tiny capillary to aim
cells one by one under a microcope. To realize automated
and high-throughput processing, a technique called “the
planar patch clamping” has been proposed, and has been
one of the most successful applications of microsystems
(Fig. 1b). In this technique, individual cells are sucked into
the small apertures etched into a substrate, instead of into
glass capillaries, to form a cell patch. Since detection of
extremely low electric current (picoamperes to nanoam-
peres) is required for ion channel recording, the choice of
the substrate material is critical. Materials that have a low
dielectric constant are generally used to avoid the noise
incurred by stray capacitance. Fertig et al. [16] performed
whole-cell patch clamping on a 1-μm-diameter aperture in a
quartz substrate created by ion-track etching. They suc-
cessfully recorded the respective ion channel currents
through the K
+ channel and the Ca
2+ channel from Chinese
hamster ovary (CHO) cells and neuroblastoma cells. By
forming a cell-membrane patch in the cell attach mode, the
same group succeeded in recording single K
+ channel
activity using the same glass aperture [17]. Klemic et al.
[18] used polydimethylsiloxane (PDMS) elastomer as a
substrate. They formed apertures as small as a few micro-
meters in diameter by casting PDMS on glass micro-
capillaries or a pyramidal mold, and recorded the K
+
Fig. 1 a The conventional
patch-clamping system with a
glass capillary. b The planar
patch-clamping system with a
microaperture
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should reduce the cost of device manufacturing. The lateral
patch-clamping configuration with the PDMS microchannel
was proposed by Lee’s group [19, 20], in which cells are
trapped into lateral recording capillaries by negative
pressure; they demonstrated the recording of a voltage-
dependent K
+ channel expressed on CHO cells. This
configuration should make manufacturing and operation
straightforward. Silicon microdevices, which offer precise
and complicated manufacturing though well-established
silicon-based microfabrication resources, provide facile
fabrication of precisely-defined microapertures as well as
integration of microfluidic systems; thus, they are expected
to be advantageous for mass production. However, success-
ful ion channel recording was not reported in early attempts
[21, 22], probably owing to the low yield and large electric
noise. The electric capacitance of the device, which is the
main cause of the stray noise, was reduced by depositing a
thick SiO2 layer (0.5–1 μm), and recording of ion channel
current in a diverse group of cell types was presented [23,
24]. Recently, Zhang et al. [25] proposed the use of a
silicon-on-insulator substrate for reduction of noise, and
demonstrated the ligand-gated activation of TRPV1 recep-
tor. All of the examples mentioned above are based on the
single-cell patch, but the most problematic issue for
realization of a high-throughput system is the reproducibil-
ity of the electrical sealing. At the single-cell level, the
success rate of gigaohm seal formation is between 30 and
50% [16]. To overcome this inconsistency, Finkel et al. [26]
proposed population patch-clamp technology, in which
cells are patch-clamped into multiple apertures in a single
recording well. Recording the ensemble signal of multiple
whole-cell clamping events increased the success rate of ion
channel recording to more than 95%. These planar patch-
clamping technologies are now applied in commercially
available automated patch-clamping systems [27, 28]. In
addition to these efforts of improving the cell-patch
configuration, Orwar’s group proposed the use of micro-
fluidic channel system to control the concentration of
ligand molecules for the study of sensitivity of GABAA
receptors [29], and to increase the seal resistance of cell-
patch [30] in regular glass-pipet based assay. Lee et al. [31]
constructed PDMS based microfluidic device for planar
patch clamping with integrated planar Ag/AgCl electrodes.
These peripheral technologies will also be necessary for
integrated recording systems.
Measurement of membrane transport
Transporters are the class of membrane proteins responsible
for transportation of numerous kinds of molecules (e.g.,
polypeptides, nucleic acids, lipids, ions, and other chemicals,
including drugs). Unlike ion channels, in which 10
6–10
7
electrons flow through a single channel per second, the
turnover number of transporter proteins is generally consid-
ered to be in the range 1–10
3 s
-1. Thus, reliable quantification
of the membrane transport of nonionic molecules has been
difficult owing to the small amount of substrate transported.
Biologists have been examining the uptake of substrates into
cells and proteoliposomes, using a radioactive substrate to
increase sensitivity [32–34]. Nonetheless, the measurement
error due to the nonspecific binding of substrates onto the
membrane has not been negligible.
Over the last decade, Peter’s group [35] has been
developing an excellent measurement technology for the
optical (fluorescence-based) detection of membrane transport
using a microwell array. In their optical single transporter
recording (OSTR) system, membranes were firmly attached
to a polycarbonate sheet with homogeneous distributions of
cylindrical pores. The flux of the fluorescent substrate across
the membrane was quantified by measuring the increase in
fluorescence intensity inside the pores using confocal laser
scanning microscopy. Transport of the fluorescent protein B-
phycoerythrin through the membrane of erythrocytes [36]
and that of the nuclear transport receptors NTF2 and GFP
through the nuclear pore complex [37] were measured
quantitatively. Since the transported substrate was concen-
trated in a tiny volume (1 aL–1p L ) ,i tb e c a m ep o s s i b l et o
detect the activity of single transporters.
Measurement of receptor activity
In the examples mentioned above, patches of the cell
membrane mounted over micropores were utilized to measure
the transport ofmolecules across themembrane.Danelonet al.
[38] proposed the use of similar cell membrane patches for
the study of receptor proteins. In this study, a Si3N4
membrane, in which holes with a diameter of 50–600 nm
were created, was pressed on adhering live cells. This
technique provides the fluidic accessibility to both extracel-
lular and intracellular surfaces of the membrane, enabling the
side-specific assay of 5HT3 receptors.
Reconstituted membrane-based systems
A lipid bilayer membrane can be artificially reconstituted in
various forms from purified or synthesized lipid molecules. In
an aqueous environment, phospholipids spontaneously self-
assemble into bilayer membranes through hydrophobic inter-
actions between their acyl chains. The utilization of artificial
lipid membranes for the analysis of membrane protein has
severaladvantagesoverintactcell-basedassays.First,itmakes
it possible to analyze the proteins in the membrane that are
difficult to access with a glass pipette or microapertures,
including proteins located in intracellular organelles. Second,
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lipid membrane and buffer, can be precisely defined for
delicate analysis. Thus, experiments in conditions far from
physiological conditions are possible. Third, unlike in experi-
ments with live cells, where protein expression levels fluctuate
widely in each cell, the population of membrane proteins in
reconstituted membranes can be controlled. In the following
sections, we introduce approaches to use microtechnologies
forthecontrolledreconstitutionofthree differentmajorclasses
of artificial bilayer membranes.
Suspended lipid bilayer systems
A planar bilayer lipid membrane (also called a black lipid
membrane, BLM) has been used for the reconstitution and
electrophysiological analysis of ion channel proteins
(Fig. 2a). A layer of nonpolar solvent containing phospho-
lipids is painted over a tiny aperture and spontaneously
becomes a biofunctional lipid bilayer as it thins down. Ion
channel proteins are typically incorporated into the bilayer
membrane by fusing the proteoliposome (liposome or
membrane fraction containing membrane proteins) by
adding the suspension into the buffer bath. A BLM
generally has a much better electrical seal than the cell
membrane patch, which helps in the detection of single ion
channel current. Since the 1970s, many types of ion
channels have been studied in this platform [39–42].
However, in these conventional BLM-forming methods
(i.e., the painting method and the Langmuir–Blodgett meth-
od), bilayer formation apertures have been fabricated by
manually shaving the indentation made on the polymer
sheet [43]. Thus, the aperture diameter is nonuniform and
relatively large (50–200 μm). Because the lipid membrane
is only 5–10-nm thick, the large planar membrane is
mechanically fragile and easily broken by small mechanical
and electrical disturbances. Thus, the stability and repro-
ducibility of the reconstituted BLM are expected to be
improved by using precisely defined micromachined
apertures.
Schmidt et al. [44] used a micromachined aperture to
reconstitute a BLM. They formed a lipid membrane by
attracting a giant liposome on a 0.6–7-μma p e r t u r eo p e n e di n
the Si3N4/SiO2 diaphragm and demonstrated a recording of
the alamethicin ion channel. Peterman et al. [45] also utilized
a silicon-based microaperture for BLM experiments. Fertig
et al. [46] performed the recording of a single gramicidin A
ion channel current using a BLM in a glass device with a
track-etched aperture (diameter approximately 1 μm), which
was also used for the patch-clamping experiments [16, 17].
P a n t o j ae ta l .[ 47] successfully recorded a single channel
current of maxi-K channels reconstituted in the BLM formed
over the silicon microaperture (diameter 200 μm). Mayer et
al. [48] thoroughly examined the size effect of the apertures
on the electric noise and the stability of a BLM with the
apertures opened in a Teflon sheet. Although electric noise
was expected to decrease with smaller BLMs, they found
that the noise from other contributions became dominant
with apertures smaller than 40 μm. Nonetheless, noise was
reduced to less than 0.4 pA rms in practice, and the BLM
was stable at voltages up to 460 mV. They also formed
multiple parallel BLMs in a single sheet to indicate the
possibility of high-throughput screening.
These early studies showed that the use of micromachined
apertures efficiently reduces electric noise and stabilizes the
BLM. However, the method of forming the BLM relied on
conventional manual techniques. Recently, several groups
have proposed the integration of microfluidic platforms to
improve the reproducibility of BLM formation to help
developparallelandaddressablesystems.Ourgroupproposed
forming BLMs in a microfluidic platform by alternately
inserting the lipid solution and buffer through a microchannel
[49]. Since the amount of lipid solution remaining over the
Fig. 2 a The planar bilayer
lipid membrane (BLM) formed
over an aperture. b Array for-
mation of 25 BLMs in a Par-
ylene sheet device. c
Simultaneous recording of ala-
methicin and gramicidin peptide
channels in the addressable par-
allel recording chip [52]
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systems, the reproducibility of the BLM formation improved
dramatically (approximately 90%) [50, 51]. In these studies,
poly(methyl methacrylate) was used as a substrate to reduce
electric noise. However, spatial resolution in the manufac-
turing of microapertures was low, because we used mechan-
ical machining. Recently, we found that the use of Parylene
film improved the formation efficiency of a lipid bilayer, on
which apertures of micrometer resolution can be easily
fabricated. Using this technology, we realized a parallel
recording in multiple independent wells in a single chip [52]
(Fig. 2b,c). Other groups have also developed methods for
the reproducible formation of BLMs. Ide and Ichikawa [53]
showed that the thinning of the lipid layer, which generally
takes a long time, can be accelerated by pressing the lipid
layer on an agarose layer. Microchannel-based BLM
formation was also performed by Morgan’sg r o u p[ 54, 55],
who successfully demonstrated the recording of KcsA ion
channels in a microfluidic platform [56]. In all of the studies
mentioned above, BLMs were formed over microapertures in
a manner analogous to conventional BLM methods. Several
groups have recently demonstrated the efficient formation of
a BLM across a microfluidic channel. We have developed a
“contact method” in which the BLM is formed by contacting
the two water interfaces separated by a solvent containing
phospholipids [57]. This method is extremely simple and
forms planar lipid bilayers reproducibly, and is thus suitable
for multiple bilayer formation in microfluidic channels. A
similar approach was described by Malmstadt et al. [58],
showing the formation of a BLM in a PDMS microchannel.
They utilized the characteristics of PDMS to absorb the sol-
vent, to drive the thinning of solvent layer between the two
monolayer interfaces. Holden et al. [59]c a r r i e do u tt h e
formation of planar membrane networks by joining multiple
droplets in hexadecane containing phospholipids, and dem-
onstrated the modulation of membrane current with bacter-
iorhodopsin. These contact-method-based approaches can
increase the flexibility in designing automated BLM-based
systems for membrane protein assays. In addition, this
method also has the potential to enable the formation of
asymmetric bilayers, as two different lipid monolayers are
brought into contact.
The BLM system has not yet been applied for the assay
of transporter proteins because of the technical issue that
small amounts of transported substrate should diffuse and
be diluted in a relatively large volume of buffer bath.
However, Peter’s group [60] also developed a BLM-based
system to detect membrane transport phenomena using the
same principle as the OSTR system mentioned above
(Fig. 3). They determined the flux of fluorescent molecules
through a single α-hemolysin peptide pore. This technol-
ogy is very promising for a transportation assay of
functional transporter proteins at the single-molecule level,
which will be a significant breakthrough in the study of
transporters.
Supported lipid bilayer systems
A supported lipid bilayer (SLB or supported BLM) is a
reconstituted membrane that is formed on the surface of a solid
substrate, which isformed by incubating aliposomesuspension
on a silicon oxide or polymer surface [61, 62]. This class of
artificial membranes has the excellent quality of being easily
micropatterned by various techniques, such as patterning of
Fig. 3 a Optical single transporter recording (OSTR) system based on
the BLM for the membrane transport assay. b Confocal images of the
bilayer membranes formed over the microwells. c Increase of
fluorescence intensity due to the transport (diffusion) of the
fluorescent substrate across the BLM and accumulation in the
microwells [60]
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65], lift-off techniques [66], and photopolymerization [67].
Because they are easily formed, stable, and versatile, many
researchers expect SLBs to be applied to biosensor applica-
tions based primarily on the interaction between membrane
proteins and ligands on the membrane surface. Some
examples of applications are in binding assays of bacterial
toxin [68], in immunological assays [69, 70], in detection of
ligand/receptor interaction [71, 72], and other membrane/
molecule interactions [73]. Generally, SLBs are not suitable
for electrophysiological measurements of ion channels owing
to their large electrical permeability. However, because SLBs
are much more stable than BLMs (SLBs lasts for many days,
while BLMs only last for hours) the effort to develop
electrochemical sensors is ongoing [74–76]. For further
information on SLB-based assay systems, readers should refer
to the excellent reviews by Sackmann and Tanaka [10],
Groves [9], Groves and Boxer [77], Groves and Dustin [78],
and Cooper [79].
Liposome-based systems
Liposomes or lipid vesicles are spherical lipid membranes.
Theyhavebeenwidelyusedasamodelcellmembranesystem
and as a cell-sized container [11, 80]. Since liposomes form
as a result of the self-assembly of lipids, it is difficult to
control their properties, such as size, lamellarity, and
entrapment efficiency. Various formation methods have been
under investigation for decades with the goal of forming
unilamellar liposomes, large or giant liposomes, and high
encapsulation efficiency, and these efforts have been
discussed in numerous papers and books [11, 80]. Reconsti-
tution of membrane proteins into liposomes is an important
research field in molecular biology and, thus, is beyond the
scope of this review. In this section, we focus on current
efforts to develop microsystems designed for liposome-based
membrane protein assays.
In conventional analysis methods, characteristics of lipo-
somes are studied as an average of the bulk suspension,
although liposomes vary greatly in size, shape, and lamellar-
ity. This diversity raises difficulties in quantitatively deter-
mining the physical constants associated with phenomena
such as encapsulation efficiency, internal reaction, and
membrane transport. Monodisperse and unilamellar lipo-
somes can be prepared by passing polydisperse liposomes
through a polycarbonate membrane with nanoscale holes
(extrusion method) [81]. However, the resulting size is
restricted to less than 1 μm in diameter, which is not
suitable for handling and optical observation of individual
liposomes. Many researchers expect microsystems to greatly
aid in the formation of monodisperse giant liposomes for
single-vesicle assays. Tan et al. [82]r e c e n t l yp r o p o s e da
method of producing uniform-sized lipid vesicles by
transferring the uniform water-in-oil emulsion into the water
phase. By carefully designing the chemical composition of
reagents, the oil phase was removed from the vesicle shell,
resulting in solvent-free liposomes. Giant unilamellar lipo-
somes can also be efficiently formed by electroformation,
although there is no size control in the conventional method
[11]. Paunov’sg r o u p[ 83, 84] demonstrated the electro-
formation of giant liposomes from micropatterned dry lipids
on an indium tin oxide substrate. The liposomes had a
narrow size distribution (5–20 μm), since the size was
determined by the number of lipids in each patterned grid.
Our group demonstrated the electroformation of liposomes in
microfluidic structures [85], and realized nearly monodis-
perse liposomes from lipids patterned by a lift-off process
using a Parylene sheet [86]. Another issue which should be
overcome in electroformation is that this technology is
usually not applicable in buffers with a high ionic concen-
tration, which limits its use for membrane protein reconsti-
tution. However, Estes and Mayer [87]u s e de l e c t r o f o r m a t i o n
to form unilamellar giant liposomes and exchanged the inner
solution with high-ionic strength buffer in a flow chamber,
and demonstrated the binding assay of protein annexin V.
Estes et al. [88] fused electroformed liposomes induced by a
fusogenic peptide in the microfluidic platform. Many expect
these technologies to be applied to membrane protein assays
to determine the physical constants in the phenomena
originating from membrane proteins, which is only possible
in single-vesicle assays [89, 90].
Conclusion
Like the microsystems designed for the assay of water-
soluble biomolecules, microfabricated structures and
microfluidic platforms are expected to improve many
aspects of membrane protein assays, making them superior
to the conventional bulk methods in areas such as reduction
of sample volume and improvement in sensitivity, repro-
ducibility, and throughput. Owing to the difficulties in
handling membranes and membrane proteins, advances in
μTAS technologies in this field have been relatively slow
in coming. However, it is certain that handy, low-cost,
reliable diagnostic tools for membrane proteins are now
strongly desired for clinical and pharmacological applica-
tions. Planar patch-clamping systems for drug screening are
commercially available. In addition, high-throughput tech-
nologies based on artificial lipid membranes are now
rapidly progressing toward the realization of sensitive and
reproducible assay systems. Other than the study of ion
channels, the assay of transporter proteins is currently the
most important avenue in cancer studies, since transporters
expressed in tumor cells export drugs out of the membrane.
The assay of receptor/ligand interaction is important for
2700 Anal Bioanal Chem (2008) 391:2695–2702screening sensory and immunological reaction represented
by the G-protein-coupled receptors. We believe that in the
near future the μTAS and biochip assay technologies for
membrane proteins will be used therapeutically as well as
in the pharmaceutical industry for rapid and/or high-
throughput screening systems.
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